{"product_id":"analysis-of-the-regulatory-requirements-for-biosimilars-in-the-eu-a-general-overview-von-kerstin-zorweg","title":"Analysis of the Regulatory Requirements for Biosimilars in the EU","description":"\u003cp\u003eA biosimilar is a biological medicinal product which is a copy of an original (innovator) product. The innovator product is often manufactured by a different company and after the patent of the innovator product expires a biosimilar can be registered in the European Union to a lower price than the innovator product. The first biosimilar in the European Union was registered in 2006 and was a Somatropin compound. Now are about 20 biosimilars registered in the European Union. Forecasts expect that there will be a huge amount of biosimilars pushing on the market in the near future and that will have a big influence on the industry.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783639888812\"\u003e\u003ch3\u003eA General Overview\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9783639888812","offer_id":39440445177949,"sku":"9783639888812","price":26.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/66669128-6811-4045-9273-b5e5d2bbc1de.jpg?v=1758171597","url":"https:\/\/shop.autorenwelt.de\/products\/analysis-of-the-regulatory-requirements-for-biosimilars-in-the-eu-a-general-overview-von-kerstin-zorweg","provider":"Autorenwelt Shop","version":"1.0","type":"link"}